CS MEDICA A/S Announces “Proof of Concept” with Successful Clinical Trial Results of CANNASEN® Pain Patch
CS MEDICA A/S (“CS MEDIA” or “The Company”), a leading MedTech company specializing in cannabis and pain management, is pleased to announce the successful completion of its clinical trial for CANNASEN® Pain PatchIn the clinical trial, CANNASEN® Pain Patch treatment was associated with significant reductions in pain intensity and was well tolerated by all patients in the treatment group. The reduction of pain was measured by the widely used WOMAC1-Pain Index, a questionnaire and index for assessing pain, stiffness, and physical function in individuals with joint degeneration and inflammation.